SlideShare a Scribd company logo
Laboratory Diagnosis of
Female Genital Tuberculosis
Prof. Ashok Rattan,
MD, MAMS, INSA DFG, WHO Lab Director
Academics, Industry: Research, Diagnosis, Public Health, Academics
A disease of great antiquity
• Fossile bones 8000 BC show evidence
• Egyptian mummies: Spinal caries 2400 BC
• 1500 BC mention of consumption in India
• Hippocrates 460 – 370 BC recognized phthisis (felt it was heredity)
Tuberculosis, Phthisis
WHO declares TB a Public Health Emergency 1993:
Recommends DOTS
• Directly
• Observed
• Therapy
• Short Term
• Detect 70% of cases
• Treat 85% of those detected
• RNTCP (2010) reported in 2014
• 100% geographical coverage
• 71% detection rate
• 87% treatment success
• 7 x decrease in death rate ( from 29 to 4%)
Tuberculosis now
There is a gathering storm of drug resistant tuberculosis and the strategy we has
Been using has failed to control the disease or prevent emergence of MDR/XDR TB
- Doctors without borders MSF Alert Fall 2006
500,000
MDR TB
2 million death
10 million cases
DOTS detects 70%
Cures 85%
2 billion persons
With latent TB
Commonest method for diagnosis of TB
1885
2017
Burden of Tuberculosis 2017
(in 1000 )
country population TB mortality
in HIV -ve
TB mortality
in HIV +ve
Incidence HIV TB
incidence
Global 7,440,000 1,300 374 10,400 1,030
India 1,324,000 423 12 2,790 87
China 1,404,000 50 1.8 895 11
Pakistan 193,000 44 2.1 518 6.9
Bangladesh 163,000 66 0.1 360 0.5
Sites of infection in FGTB
90 – 100 % 
50 – 80 % 
20 – 30 % 
5 – 15 % 
1 – 2 % 
Epidemiology
Prevalence & Incidence of FGTB
• USA : 1% in women attending infertility clinics
• South Africa: 6 – 21 %
• India: 1 – 19%
• In infertility patients FGTB incidence varies from 3 to 16%
• In AIIMS, New Delhi [Suneeta Mittal, JB Sharma] 26 %
• Incidence of infertility in FGTB [AIIMS] 42.5%
• Women seeking assisted reproduction [AIIMS] 24 %
• Tubal factor infertility [AIIMS] 48.5%
Investigations
• Common Investigations:
• Blood & Urine Examination
• Chest X Ray
• Mycobacterium based
• TST or IGRA
• Smear examination
• Culture
• Histopathology
• Gene Xpert
• Additional Investigations:
• Imaging
• Endoscopy
• PET/CT
• Biomarkers [LTBI vs Active TB]
Acceptable specimens
• Endometrial biopsy / curettage / aspiration
• Menstrual blood within 12 hours of onset
• Biopsy from TO mass
• Peritoneal fluid / biopsy
• Cx or Vaginal secretion
• Other supportive samples
• Sputum for AFB/culture/Gene Xpert
• Blood
The First Choice Diagnostic Laboratory
Smear examination
[revised national TB control program RNTCP]
• ZN method
• Kinyoun cold stain
• Auromine O
• Rapid, economical, simple
• Adequate sensitivity in symptomatics
• Overall Low sensitivity (22 – 78% of culture)
• Limit of detection 1 x 104 vs 102 bacilli/ml
• Species cannot be identified
How to improve microscopy
LED Microscopy
• Fluorescent microscope
• Pro:
• High power rather than oil immersion
• Black background, yellow bacilli
• Increased sensitivity by 10%
• Con:
• High cost, maintenance
• FluoLED Microscopy
The First Choice Diagnostic Laboratory
Loop mediated Isothermal Amplification (LAMP)
Culture based detection
Gold standard
Slow : weeks
Low sensitivity
Improving detection
• CO2 production
• O2 consumption
– Radiometric
– Fluorescent
– Colourimetric
– Pressure sensor
– Decrease TAT by half
•14 C Palmitate  14 CO2
Speed Of Growth Of M.tuberculosis (MGIT 960 vs L J Media)
1st wk 2nd wk 3rd wk 4th wk 5th wk 6th wk
166
0
132
23
55
46
23
63
13
48
2
24
391 204
Gene expert
Gene Xpert
533 150 [S+ 92, S- 58] 129 4
533
150
92
58
129
4
250
MDR 50; HIV 16
Gene Xpert MTB/RIF assay in the diagnosis of urinary
tuberculosis from urine specimen
Yu Pang et al. Scientific Reports, Nature: 2017; 7: 6181
Diagnostic usefulness of Xpert MTB/RIF assay for detection of
tuberculous meningitis using CSF
Syed Beenish Rufai et al. J Infect 2017; 75 (2): 125
• 267 CSF samples
• Smear by ZN -ve
• MGIT 52 (19.5%) 5 RIF resistant
• Xpert 38 (14.2%) 4 Rif R, 3 RIF I, 31 RIF S
• Xpert has sensitivity of 55.1%
• specificity of 94.8%
Genotype Mycobacterium test [Hain’s Test]
• DNA Strip technology: Three steps
• 1. DNA isolated from culture
• 2. Multiplex amplification with biotinylated primers  230 bp product
• 3. Reverse hybridization:
• Chemical denaturation of amplified product
• Hybridization of SS biotin labeled amplicon to membrane bound probes
• Stringent washing
• Addition of Steptavidin/alkaline phosphatase
• AP mediated staining reaction
The First Choice Diagnostic Laboratory
Genotype MTBDR assay
M. tuberculosis
Drug susceptibile
XDR
M. tuberculosis
Drug susceptible
INH + RIF Resistant
= MDR
FQ
Resistant
Injectable
Resistant
MDR [multiple drug resistant] TB XDR [extensively drug resistant] TB
1st line drugs
2nd line drugs
INH INH
RIF RIF
PZA PZA
Etham Etham
FQ FQ
Injectable Injectable
Ethio Ethio
Cyclo Cyclo
PAS PAS
MDR TB XDR TB
2 most important
2 most important
Antibodies tests
• From Agglutination to SAFA all techniques have been tried
• Cannot differentiate between infection and disease
• Positive even in healthy individuals
• WHO and GOI have banned the use of Antibody tests
In Vitro Diagnostic Tests
Antigen
presenting
cell
Memory
T-cell
Presentation of
mycobacterial antigens
IFN-
IFN-
IL-8, etc.
IL-8, etc.
TNF-
TNF-
Andersen P, et al. Lancet 2000;356:1099
ESAT 6 & CFP 10
Specific antigens of M. tuberculosis
(RD 1 region)
3rd Generation
Quantiferon TB Gold IT (in Tube method)
• Grey cap tube (Nil control)
• Red cap tube (TB Ag)
• Purple cap tube (Mitogen control)
• Collect 1 ml blood into each tube and mix well
• Transfer to Lab ASAP
RESULT INTERPRETATION
POSITIVE ESAT-6 and/or CFP-10
responsiveness detected
M. tuberculosis infection likely
NEGATIVE No ESAT-6 or CFP-10
responsiveness detected
M. tuberculosis unlikely
INDETERMINATE MTB infection status cannot be
determined as a result of
impaired immunity and/or
incorrect performance of the
test
Genital TB Algorithm
21st century approach
Tests Results TAT
Smear &/or
culture
+ -- -- + -- 24 hrs
6 wks
Gene Xpert + + -- -- -- 4 hrs
Quantiferon
Gold IT or
Platinum
+ + + -- -- 48 hrs
Diagnosis Genital TB Genital TB Latent TB MOTT
contamination
No evidence
of TB
infection
10 days
Carry Home Messages : Diagnostic Methods
[Genital TB is nearly always secondary to TB elsewhere]
1. Smear is inexpensive, rapid but insensitive (104 AFB/ml), can be
improved by using Fluorescent Microscopy (103 AFB/ml)
2. Liquid culture is sensitive & specific [102 M tb/ml], faster than solid
culture but still slow, isolate available for additional AST
3. IGRA is better than TST: both detect LTBI
4. Serological tests, have been banned, as they had no diagnostic value
5. Gene Xpert is sensitive & specific for M tb: both pulmonary & extra
6. Diagnostic tests : culture & non culture tests should be used
simultaneously in an algorithm to improve definitive diagnosis
Female genital tuberculosis

More Related Content

What's hot

Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
NARENDRA MALHOTRA
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
Niranjan Chavan
 
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANILETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANITHYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Diagnosis and management of male infertility
Diagnosis and management of male infertilityDiagnosis and management of male infertility
Diagnosis and management of male infertilityDR SHASHWAT JANI
 
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Lifecare Centre
 
female Genital tuberculosis,TB-PCR, female infertility,
female Genital tuberculosis,TB-PCR, female infertility, female Genital tuberculosis,TB-PCR, female infertility,
female Genital tuberculosis,TB-PCR, female infertility,
veerendrakumar cm
 
Male Infertility
Male InfertilityMale Infertility
Male Infertility
Sujoy Dasgupta
 
Induction of ovulation
Induction of ovulationInduction of ovulation
Induction of ovulation
muhammad al hennawy
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Sujoy Dasgupta
 
Amh and ovarian reserve
Amh and ovarian reserveAmh and ovarian reserve
Amh and ovarian reserve
Sundar Narayanan
 
Colposcopy examination
Colposcopy examinationColposcopy examination
Colposcopy examination
Archana Rajendran
 
Polycystic Ovarian Syndrome (PCOS) by Dr. Aryan
Polycystic Ovarian Syndrome (PCOS) by Dr. AryanPolycystic Ovarian Syndrome (PCOS) by Dr. Aryan
Polycystic Ovarian Syndrome (PCOS) by Dr. Aryan
Dr. Aryan (Anish Dhakal)
 
Dept. of Health cervical cancer fogsi_ screening test npcdcs_dept. of genera...
Dept. of Health  cervical cancer fogsi_ screening test npcdcs_dept. of genera...Dept. of Health  cervical cancer fogsi_ screening test npcdcs_dept. of genera...
Dept. of Health cervical cancer fogsi_ screening test npcdcs_dept. of genera...
drdduttaM
 
Genital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalitiesGenital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalities
Dr Anusha Rao P
 
Syndromic management of sexually transmitted disease
Syndromic management of sexually transmitted diseaseSyndromic management of sexually transmitted disease
Syndromic management of sexually transmitted disease
MonicapreetKaur
 
Cbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat AbhishekCbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat Abhishek
Samrat Abhishek
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
Niranjan Chavan
 
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
Lifecare Centre
 
Anti mullerian hormone
Anti mullerian hormoneAnti mullerian hormone
Anti mullerian hormone
Deepak Sanghavi
 

What's hot (20)

Screening what tests when
Screening what tests whenScreening what tests when
Screening what tests when
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
 
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANILETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
LETROZOLE - A WONDER DRUG FOR OVULATION INDUCTION BY DR SHASHWAT JANI
 
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANITHYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
 
Diagnosis and management of male infertility
Diagnosis and management of male infertilityDiagnosis and management of male infertility
Diagnosis and management of male infertility
 
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
Luteal Phase Defect Contributors Dr.Shweta Mittal Gupta & DGF Team Experts
 
female Genital tuberculosis,TB-PCR, female infertility,
female Genital tuberculosis,TB-PCR, female infertility, female Genital tuberculosis,TB-PCR, female infertility,
female Genital tuberculosis,TB-PCR, female infertility,
 
Male Infertility
Male InfertilityMale Infertility
Male Infertility
 
Induction of ovulation
Induction of ovulationInduction of ovulation
Induction of ovulation
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
 
Amh and ovarian reserve
Amh and ovarian reserveAmh and ovarian reserve
Amh and ovarian reserve
 
Colposcopy examination
Colposcopy examinationColposcopy examination
Colposcopy examination
 
Polycystic Ovarian Syndrome (PCOS) by Dr. Aryan
Polycystic Ovarian Syndrome (PCOS) by Dr. AryanPolycystic Ovarian Syndrome (PCOS) by Dr. Aryan
Polycystic Ovarian Syndrome (PCOS) by Dr. Aryan
 
Dept. of Health cervical cancer fogsi_ screening test npcdcs_dept. of genera...
Dept. of Health  cervical cancer fogsi_ screening test npcdcs_dept. of genera...Dept. of Health  cervical cancer fogsi_ screening test npcdcs_dept. of genera...
Dept. of Health cervical cancer fogsi_ screening test npcdcs_dept. of genera...
 
Genital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalitiesGenital Tuberculosis- Newer trends in the diagnostic modalities
Genital Tuberculosis- Newer trends in the diagnostic modalities
 
Syndromic management of sexually transmitted disease
Syndromic management of sexually transmitted diseaseSyndromic management of sexually transmitted disease
Syndromic management of sexually transmitted disease
 
Cbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat AbhishekCbnaat ppt by Dr. Samrat Abhishek
Cbnaat ppt by Dr. Samrat Abhishek
 
OVARIAN TUMOURS
OVARIAN TUMOURSOVARIAN TUMOURS
OVARIAN TUMOURS
 
NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre NIPT, Dr. Sharda Jain, Life Care centre
NIPT, Dr. Sharda Jain, Life Care centre
 
Anti mullerian hormone
Anti mullerian hormoneAnti mullerian hormone
Anti mullerian hormone
 

Similar to Female genital tuberculosis

Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019
PathKind Labs
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TB
Dr.Akhilesh kunoor
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
PathKind Labs
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2
Dr.Akhilesh kunoor
 
Diagnosis of Female Genital TB
Diagnosis of Female Genital TBDiagnosis of Female Genital TB
Diagnosis of Female Genital TB
Anuj Sharma
 
Stci abhijit nov'17
Stci  abhijit nov'17Stci  abhijit nov'17
Stci abhijit nov'17
Abhijit Dey
 
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
Open Access Research Paper
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPnavinthakkar
 
Gene Xpert & Advances
Gene Xpert & AdvancesGene Xpert & Advances
Gene Xpert & Advances
AIIMS, New Delhi, India
 
Current tuberculosis management in short
Current tuberculosis management in shortCurrent tuberculosis management in short
Current tuberculosis management in short
Subhajit Ghosh
 
Diagnostic modalities tb final edited
Diagnostic modalities tb final editedDiagnostic modalities tb final edited
Diagnostic modalities tb final edited
Shivaom Chaurasia
 
Importance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseasesImportance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseases
Central Govt, India
 
Diagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosisDiagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosis
biplave karki
 
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
Aditya Singh
 
Diagnosis of Tuberculosis an Update
Diagnosis of Tuberculosis an Update Diagnosis of Tuberculosis an Update
Diagnosis of Tuberculosis an Update
Society for Microbiology and Infection care
 
Tuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
Tuberculosis- International Perspectives on Epidemiology, diagnosis and ControlsTuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
Tuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
Ranjini Manuel
 
biofire presentation.pptx
biofire presentation.pptxbiofire presentation.pptx
biofire presentation.pptx
AdityaShukla514007
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
CICM 2019 Annual Scientific Meeting
 
Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...
UC San Diego AntiViral Research Center
 

Similar to Female genital tuberculosis (20)

Tb sure ultra short july 2019
Tb sure ultra short july 2019Tb sure ultra short july 2019
Tb sure ultra short july 2019
 
INDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TBINDEX TB GUIDELINE - EXTRA PULMONARY TB
INDEX TB GUIDELINE - EXTRA PULMONARY TB
 
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptxwhat is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
what is new in prevention, diagnosis and treatment of tuberculosis tb short.pptx
 
Index tb guideline eptb final2
Index tb guideline  eptb final2Index tb guideline  eptb final2
Index tb guideline eptb final2
 
Diagnosis of Female Genital TB
Diagnosis of Female Genital TBDiagnosis of Female Genital TB
Diagnosis of Female Genital TB
 
Stci abhijit nov'17
Stci  abhijit nov'17Stci  abhijit nov'17
Stci abhijit nov'17
 
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
Evaluation of pcr in the molecular diagnosis of trichomonas vaginalis infecti...
 
Diagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCPDiagnosis & management of tb in RNTCP
Diagnosis & management of tb in RNTCP
 
Gene Xpert & Advances
Gene Xpert & AdvancesGene Xpert & Advances
Gene Xpert & Advances
 
Current tuberculosis management in short
Current tuberculosis management in shortCurrent tuberculosis management in short
Current tuberculosis management in short
 
Diagnostic modalities tb final edited
Diagnostic modalities tb final editedDiagnostic modalities tb final edited
Diagnostic modalities tb final edited
 
Importance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseasesImportance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseases
 
Diagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosisDiagnostic modalities in tuberculosis
Diagnostic modalities in tuberculosis
 
Sbp
SbpSbp
Sbp
 
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
Laboratory diagnosis of Tuberculosis (Pulmonary and extra pulmonary Tuberculo...
 
Diagnosis of Tuberculosis an Update
Diagnosis of Tuberculosis an Update Diagnosis of Tuberculosis an Update
Diagnosis of Tuberculosis an Update
 
Tuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
Tuberculosis- International Perspectives on Epidemiology, diagnosis and ControlsTuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
Tuberculosis- International Perspectives on Epidemiology, diagnosis and Controls
 
biofire presentation.pptx
biofire presentation.pptxbiofire presentation.pptx
biofire presentation.pptx
 
HIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison RatcliffHIV and Hepatitis C by Dr Alison Ratcliff
HIV and Hepatitis C by Dr Alison Ratcliff
 
Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...Preventing TB infection in HIV-infected individuals living in medium and high...
Preventing TB infection in HIV-infected individuals living in medium and high...
 

More from PathKind Labs

ISO 15189 2022 standards for laboratory quality and competence
ISO 15189 2022 standards for laboratory quality and competenceISO 15189 2022 standards for laboratory quality and competence
ISO 15189 2022 standards for laboratory quality and competence
PathKind Labs
 
iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptx
PathKind Labs
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptx
PathKind Labs
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptx
PathKind Labs
 
iso 15189.pptx
iso 15189.pptxiso 15189.pptx
iso 15189.pptx
PathKind Labs
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
PathKind Labs
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptx
PathKind Labs
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptx
PathKind Labs
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptx
PathKind Labs
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptx
PathKind Labs
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic use
PathKind Labs
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19
PathKind Labs
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose short
PathKind Labs
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb
PathKind Labs
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosis
PathKind Labs
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosis
PathKind Labs
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
PathKind Labs
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinations
PathKind Labs
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and how
PathKind Labs
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 short
PathKind Labs
 

More from PathKind Labs (20)

ISO 15189 2022 standards for laboratory quality and competence
ISO 15189 2022 standards for laboratory quality and competenceISO 15189 2022 standards for laboratory quality and competence
ISO 15189 2022 standards for laboratory quality and competence
 
iso 15189 short.pptx
iso 15189 short.pptxiso 15189 short.pptx
iso 15189 short.pptx
 
behaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptxbehaviour changes for success of antimicrobial stewardship program.pptx
behaviour changes for success of antimicrobial stewardship program.pptx
 
management of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptxmanagement of childhood tuberculosis in 2023.pptx
management of childhood tuberculosis in 2023.pptx
 
iso 15189.pptx
iso 15189.pptxiso 15189.pptx
iso 15189.pptx
 
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptxviral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
viral markers in diagnosis monitoring and treatment of hepatitis b and c.pptx
 
tackling an invisible pandemic.pptx
tackling an invisible pandemic.pptxtackling an invisible pandemic.pptx
tackling an invisible pandemic.pptx
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptx
 
clinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptxclinical standards for ds tb treatment 2022 (1).pptx
clinical standards for ds tb treatment 2022 (1).pptx
 
Seven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptxSeven strategies to prevent hospital associated infections improved.pptx
Seven strategies to prevent hospital associated infections improved.pptx
 
29 nov pct guided antibiotic use
29 nov pct guided antibiotic use29 nov pct guided antibiotic use
29 nov pct guided antibiotic use
 
Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19Role of neutralizing antibodies in covid 19
Role of neutralizing antibodies in covid 19
 
What is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose shortWhat is and what is not black fungus and how to diagnose short
What is and what is not black fungus and how to diagnose short
 
24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb24 march short ntep who diagnosis of dr tb
24 march short ntep who diagnosis of dr tb
 
18 march what is new in tuberculosis
18 march what is new in tuberculosis18 march what is new in tuberculosis
18 march what is new in tuberculosis
 
what is new in tuberculosis
what is new in tuberculosiswhat is new in tuberculosis
what is new in tuberculosis
 
Understanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratoriesUnderstanding and implementing quality management system in medical laboratories
Understanding and implementing quality management system in medical laboratories
 
Essential information on covid 19 vaccinations
Essential information on covid 19 vaccinationsEssential information on covid 19 vaccinations
Essential information on covid 19 vaccinations
 
Rapid antigen test when and how
Rapid antigen test when and howRapid antigen test when and how
Rapid antigen test when and how
 
role serology in diagnosis and control of covid 19 short
 role serology in diagnosis and control of covid 19 short role serology in diagnosis and control of covid 19 short
role serology in diagnosis and control of covid 19 short
 

Recently uploaded

GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
TheDocs
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Health Catalyst
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
Esam43
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
KRISTELLEGAMBOA2
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 

Recently uploaded (20)

GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........The Docs PPG - 30.05.2024.pptx..........
The Docs PPG - 30.05.2024.pptx..........
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondEmpowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
CANCER CANCER CANCER CANCER CANCER CANCER
CANCER  CANCER  CANCER  CANCER  CANCER CANCERCANCER  CANCER  CANCER  CANCER  CANCER CANCER
CANCER CANCER CANCER CANCER CANCER CANCER
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 

Female genital tuberculosis

  • 1.
  • 2. Laboratory Diagnosis of Female Genital Tuberculosis Prof. Ashok Rattan, MD, MAMS, INSA DFG, WHO Lab Director Academics, Industry: Research, Diagnosis, Public Health, Academics
  • 3. A disease of great antiquity • Fossile bones 8000 BC show evidence • Egyptian mummies: Spinal caries 2400 BC • 1500 BC mention of consumption in India • Hippocrates 460 – 370 BC recognized phthisis (felt it was heredity) Tuberculosis, Phthisis
  • 4. WHO declares TB a Public Health Emergency 1993: Recommends DOTS • Directly • Observed • Therapy • Short Term • Detect 70% of cases • Treat 85% of those detected • RNTCP (2010) reported in 2014 • 100% geographical coverage • 71% detection rate • 87% treatment success • 7 x decrease in death rate ( from 29 to 4%)
  • 5. Tuberculosis now There is a gathering storm of drug resistant tuberculosis and the strategy we has Been using has failed to control the disease or prevent emergence of MDR/XDR TB - Doctors without borders MSF Alert Fall 2006 500,000 MDR TB 2 million death 10 million cases DOTS detects 70% Cures 85% 2 billion persons With latent TB
  • 6.
  • 7. Commonest method for diagnosis of TB 1885 2017
  • 8. Burden of Tuberculosis 2017 (in 1000 ) country population TB mortality in HIV -ve TB mortality in HIV +ve Incidence HIV TB incidence Global 7,440,000 1,300 374 10,400 1,030 India 1,324,000 423 12 2,790 87 China 1,404,000 50 1.8 895 11 Pakistan 193,000 44 2.1 518 6.9 Bangladesh 163,000 66 0.1 360 0.5
  • 9.
  • 10. Sites of infection in FGTB 90 – 100 %  50 – 80 %  20 – 30 %  5 – 15 %  1 – 2 % 
  • 11. Epidemiology Prevalence & Incidence of FGTB • USA : 1% in women attending infertility clinics • South Africa: 6 – 21 % • India: 1 – 19% • In infertility patients FGTB incidence varies from 3 to 16% • In AIIMS, New Delhi [Suneeta Mittal, JB Sharma] 26 % • Incidence of infertility in FGTB [AIIMS] 42.5% • Women seeking assisted reproduction [AIIMS] 24 % • Tubal factor infertility [AIIMS] 48.5%
  • 12. Investigations • Common Investigations: • Blood & Urine Examination • Chest X Ray • Mycobacterium based • TST or IGRA • Smear examination • Culture • Histopathology • Gene Xpert • Additional Investigations: • Imaging • Endoscopy • PET/CT • Biomarkers [LTBI vs Active TB]
  • 13.
  • 14. Acceptable specimens • Endometrial biopsy / curettage / aspiration • Menstrual blood within 12 hours of onset • Biopsy from TO mass • Peritoneal fluid / biopsy • Cx or Vaginal secretion • Other supportive samples • Sputum for AFB/culture/Gene Xpert • Blood
  • 15. The First Choice Diagnostic Laboratory Smear examination [revised national TB control program RNTCP] • ZN method • Kinyoun cold stain • Auromine O • Rapid, economical, simple • Adequate sensitivity in symptomatics • Overall Low sensitivity (22 – 78% of culture) • Limit of detection 1 x 104 vs 102 bacilli/ml • Species cannot be identified
  • 16. How to improve microscopy LED Microscopy • Fluorescent microscope • Pro: • High power rather than oil immersion • Black background, yellow bacilli • Increased sensitivity by 10% • Con: • High cost, maintenance • FluoLED Microscopy
  • 17. The First Choice Diagnostic Laboratory Loop mediated Isothermal Amplification (LAMP)
  • 18. Culture based detection Gold standard Slow : weeks Low sensitivity
  • 19. Improving detection • CO2 production • O2 consumption – Radiometric – Fluorescent – Colourimetric – Pressure sensor – Decrease TAT by half •14 C Palmitate  14 CO2
  • 20. Speed Of Growth Of M.tuberculosis (MGIT 960 vs L J Media) 1st wk 2nd wk 3rd wk 4th wk 5th wk 6th wk 166 0 132 23 55 46 23 63 13 48 2 24 391 204
  • 22.
  • 23.
  • 24. 533 150 [S+ 92, S- 58] 129 4 533 150 92 58 129 4 250 MDR 50; HIV 16
  • 25.
  • 26.
  • 27. Gene Xpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimen Yu Pang et al. Scientific Reports, Nature: 2017; 7: 6181
  • 28. Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using CSF Syed Beenish Rufai et al. J Infect 2017; 75 (2): 125 • 267 CSF samples • Smear by ZN -ve • MGIT 52 (19.5%) 5 RIF resistant • Xpert 38 (14.2%) 4 Rif R, 3 RIF I, 31 RIF S • Xpert has sensitivity of 55.1% • specificity of 94.8%
  • 29.
  • 30.
  • 31. Genotype Mycobacterium test [Hain’s Test] • DNA Strip technology: Three steps • 1. DNA isolated from culture • 2. Multiplex amplification with biotinylated primers  230 bp product • 3. Reverse hybridization: • Chemical denaturation of amplified product • Hybridization of SS biotin labeled amplicon to membrane bound probes • Stringent washing • Addition of Steptavidin/alkaline phosphatase • AP mediated staining reaction
  • 32. The First Choice Diagnostic Laboratory
  • 34. M. tuberculosis Drug susceptibile XDR M. tuberculosis Drug susceptible INH + RIF Resistant = MDR FQ Resistant Injectable Resistant MDR [multiple drug resistant] TB XDR [extensively drug resistant] TB
  • 35. 1st line drugs 2nd line drugs INH INH RIF RIF PZA PZA Etham Etham FQ FQ Injectable Injectable Ethio Ethio Cyclo Cyclo PAS PAS MDR TB XDR TB 2 most important 2 most important
  • 36. Antibodies tests • From Agglutination to SAFA all techniques have been tried • Cannot differentiate between infection and disease • Positive even in healthy individuals • WHO and GOI have banned the use of Antibody tests
  • 37. In Vitro Diagnostic Tests Antigen presenting cell Memory T-cell Presentation of mycobacterial antigens IFN- IFN- IL-8, etc. IL-8, etc. TNF- TNF- Andersen P, et al. Lancet 2000;356:1099
  • 38. ESAT 6 & CFP 10 Specific antigens of M. tuberculosis (RD 1 region)
  • 39. 3rd Generation Quantiferon TB Gold IT (in Tube method) • Grey cap tube (Nil control) • Red cap tube (TB Ag) • Purple cap tube (Mitogen control) • Collect 1 ml blood into each tube and mix well • Transfer to Lab ASAP
  • 40. RESULT INTERPRETATION POSITIVE ESAT-6 and/or CFP-10 responsiveness detected M. tuberculosis infection likely NEGATIVE No ESAT-6 or CFP-10 responsiveness detected M. tuberculosis unlikely INDETERMINATE MTB infection status cannot be determined as a result of impaired immunity and/or incorrect performance of the test
  • 41. Genital TB Algorithm 21st century approach Tests Results TAT Smear &/or culture + -- -- + -- 24 hrs 6 wks Gene Xpert + + -- -- -- 4 hrs Quantiferon Gold IT or Platinum + + + -- -- 48 hrs Diagnosis Genital TB Genital TB Latent TB MOTT contamination No evidence of TB infection 10 days
  • 42. Carry Home Messages : Diagnostic Methods [Genital TB is nearly always secondary to TB elsewhere] 1. Smear is inexpensive, rapid but insensitive (104 AFB/ml), can be improved by using Fluorescent Microscopy (103 AFB/ml) 2. Liquid culture is sensitive & specific [102 M tb/ml], faster than solid culture but still slow, isolate available for additional AST 3. IGRA is better than TST: both detect LTBI 4. Serological tests, have been banned, as they had no diagnostic value 5. Gene Xpert is sensitive & specific for M tb: both pulmonary & extra 6. Diagnostic tests : culture & non culture tests should be used simultaneously in an algorithm to improve definitive diagnosis